| Serial Number | 97270470 |
| Word Mark | CG CG PHARMACEUTICALS |
| Filing Date | Wednesday, February 16, 2022 |
| Status | 731 - SECOND EXTENSION - GRANTED |
| Status Date | Tuesday, October 1, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, August 8, 2023 |
| Goods and Services | Educational services, namely, conducting seminars regarding the use of prescription pharmaceutical products for medical disorders and dissemination of materials in connection therewith; providing motivational and educational speakers featuring information regarding medical disorders; conducting educational seminars in the field of medicine, medical disorders, cancer treatment and diagnosis, biologics, and pharmaceutical products and dissemination of materials in connection therewith; educational services, namely, conducting classes, seminars, conferences or workshops in the field of medicine, medical disorders, cancer treatment and diagnosis, biologics, and pharmaceutical products |
| Description of Mark | The mark consists of the term CG PHARMACEUTICALS in a stylized format with a stylized CG on top. |
| Goods and Services | biopharmaceutical preparations for the treatment of cancer; biopharmaceutical preparations for the treatment of chronic diseases, namely, dementia, Alzheimer's disease, arthritis, rheumatoid arthritis, fibrosis, pulmonary fibrosis, idiopathic pulmonary fibrosis, kidney disease, inflammatory bowel disease, gastrointestinal disease, infectious diseases, neurodegenerative diseases, immunological disorders, and inflammatory diseases; biologic preparations for the treatment of cancer; biologic preparations for the treatment of chronic diseases, namely, dementia, Alzheimer's disease, arthritis, rheumatoid arthritis, fibrosis, pulmonary fibrosis, idiopathic pulmonary fibrosis, kidney disease, inflammatory bowel disease, gastrointestinal disease, infectious diseases, neurodegenerative diseases, immunological disorders, and inflammatory diseases; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of chronic diseases, namely, dementia, Alzheimer's disease, arthritis, rheumatoid arthritis, fibrosis, pulmonary fibrosis, idiopathic pulmonary fibrosis, kidney disease, inflammatory bowel disease, gastrointestinal disease, infectious diseases, neurodegenerative diseases, immunological disorders, and inflammatory diseases; pharmaceutical preparations and substances for use in oncology treatment; pharmaceuticals for the treatment of cancer; prescription pharmaceuticals for treatment of diseases and disorders, namely, cancer and chronic diseases |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Providing health and medical information about medical disorders and their diagnosis, prevention and treatment; information and advisory services relating to pharmaceuticals, diseases and medical conditions and treatments, including pharmaceutical advice, medical and pharmaceutical consultation, medical advisory services, and providing medical information, consultancy and advisory services; information and advisory services relating to pharmaceuticals, diseases and medical conditions and treatments, including pharmaceutical advice, medical and pharmaceutical consultation, medical advisory services, and providing medical information, consultancy and advisory services provided on-line over a computer network and the Internet; Providing information regarding medical conditions; medical information services; providing medical information regarding testing, diagnosis, and treatment of diseases; providing medical information to patients regarding disease management and medication |
| NOT AVAILABLE | "PHARMACEUTICALS" |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 22, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 22, 2022 |
| Primary Code | 041 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 22, 2022 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | CG Pharmaceuticals, Inc |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Orinda, CA 94563 |
| Party Name | CG Pharmaceuticals, Inc |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Orinda, CA 94563 |
| Event Date | Event Description |
| Thursday, December 1, 2022 | NON-FINAL ACTION WRITTEN |
| Saturday, February 19, 2022 | NEW APPLICATION ENTERED |
| Tuesday, February 22, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, November 30, 2022 | ASSIGNED TO EXAMINER |
| Thursday, December 1, 2022 | NON-FINAL ACTION E-MAILED |
| Thursday, December 1, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, June 1, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, June 1, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, June 2, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Sunday, July 2, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, August 8, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, August 8, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 3, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, July 19, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 2, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, April 2, 2024 | SOU EXTENSION 1 FILED |
| Wednesday, April 3, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, October 1, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, October 1, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, October 1, 2024 | SOU EXTENSION 2 GRANTED |
| Tuesday, October 1, 2024 | SOU EXTENSION 2 FILED |
| Tuesday, April 2, 2024 | SOU EXTENSION 1 GRANTED |